首页 > 最新文献

Clinical and Public Health Guidelines最新文献

英文 中文
Planetary Health in Health Guidelines and Health Technology Assessments: A Scoping Review 健康指南和卫生技术评估中的地球健康:范围审查
Pub Date : 2025-12-13 DOI: 10.1002/gin2.70056
Pakeezah Saadat, Maheen Raja, Andrea J. Darzi, Charlotte T. J. Michels, Alina Herrmann, Karolina Anna Scahill, Laura M. Jewell, K. M. Saif-Ur-Rahman, Hendrik Napierala, Ruben Heuer, Rebecca L. Morgan, Grigorios I. Leontiadis, Ignacio Neumann, Fiona A. Miller, Holger J. Schünemann, Thomas Piggott

Introduction

Individual human health is inextricably linked to planetary health, which refers to the health of human civilization and the natural systems on which it depends. These systems are captured by the nine planetary boundaries which together define a safe operating space for humanity. The health sector contributes to the transgression of these boundaries, thereby jeopardizing both individual and planetary health. However, there is a growing interest in the health sector in incorporating the preservation of planetary boundaries into health guidelines and health technology assessments (HTAs), which synthesize evidence and guide healthcare decisions.

Methods

This scoping review aims to describe methodological guidance and considerations for incorporating planetary health in health guidelines and HTAs. We conducted a scoping review adhering to the JBI methodology including articles from several databases since inception until September 2023. We used narrative synthesis and descriptive statistics to describe eligible studies.

Results

Of the 38 included studies, 14 (37%) were commentaries, six (16%) were methodological papers, and four (10·5%) were health guidelines. Included studies focused primarily on greenhouse gas emissions as an outcome. The included health guidelines were rated at a median of 52% (range: 16% to 67%) on AGREE II for methodological quality.

Discussion

Key findings pertain to the normative significance of planetary health in guidelines and HTAs, scope and quality of included studies, inconsistencies in methods, and challenges in implementation. These findings will inform future Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) guidance on planetary health.

Registration

A protocol of this scoping review was registered in Open Science Framework (https://osf.io/3jmsa) and published in the journal Systematic Reviews (10.1186/s13643-024-02577-2).

个人健康与地球健康密不可分,地球健康是指人类文明及其赖以生存的自然系统的健康。这些系统被九个行星边界所捕获,它们共同定义了人类的安全操作空间。卫生部门助长了这些界限的越界,从而危害了个人和地球的健康。然而,卫生部门越来越有兴趣将保护地球边界纳入卫生准则和卫生技术评估(hta),这些准则和技术评估综合证据并指导卫生保健决策。方法本综述的目的是描述将地球健康纳入健康指南和hta的方法学指导和考虑因素。我们根据JBI方法进行了范围审查,包括从成立到2023年9月的几个数据库中的文章。我们使用叙述性综合和描述性统计来描述符合条件的研究。结果纳入的38篇研究中,14篇(37%)为评论,6篇(16%)为方法学论文,4篇(10.5%)为健康指南。纳入的研究主要集中在温室气体排放上。纳入的健康指南在方法学质量方面的评价中位数为52%(范围:16%至67%)。主要发现涉及指南和技术指导文件中行星健康的规范意义、纳入研究的范围和质量、方法的不一致以及实施中的挑战。这些发现将为今后关于地球健康的建议、评估、发展和评价(GRADE)指南的分级提供信息。本综述的方案已在Open Science Framework (https://osf.io/3jmsa)上注册,并发表在期刊Systematic Reviews (10.1186/s13643-024-02577-2)上。
{"title":"Planetary Health in Health Guidelines and Health Technology Assessments: A Scoping Review","authors":"Pakeezah Saadat,&nbsp;Maheen Raja,&nbsp;Andrea J. Darzi,&nbsp;Charlotte T. J. Michels,&nbsp;Alina Herrmann,&nbsp;Karolina Anna Scahill,&nbsp;Laura M. Jewell,&nbsp;K. M. Saif-Ur-Rahman,&nbsp;Hendrik Napierala,&nbsp;Ruben Heuer,&nbsp;Rebecca L. Morgan,&nbsp;Grigorios I. Leontiadis,&nbsp;Ignacio Neumann,&nbsp;Fiona A. Miller,&nbsp;Holger J. Schünemann,&nbsp;Thomas Piggott","doi":"10.1002/gin2.70056","DOIUrl":"https://doi.org/10.1002/gin2.70056","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Individual human health is inextricably linked to planetary health, which refers to the health of human civilization and the natural systems on which it depends. These systems are captured by the nine planetary boundaries which together define a safe operating space for humanity. The health sector contributes to the transgression of these boundaries, thereby jeopardizing both individual and planetary health. However, there is a growing interest in the health sector in incorporating the preservation of planetary boundaries into health guidelines and health technology assessments (HTAs), which synthesize evidence and guide healthcare decisions.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This scoping review aims to describe methodological guidance and considerations for incorporating planetary health in health guidelines and HTAs. We conducted a scoping review adhering to the JBI methodology including articles from several databases since inception until September 2023. We used narrative synthesis and descriptive statistics to describe eligible studies.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Of the 38 included studies, 14 (37%) were commentaries, six (16%) were methodological papers, and four (10·5%) were health guidelines. Included studies focused primarily on greenhouse gas emissions as an outcome. The included health guidelines were rated at a median of 52% (range: 16% to 67%) on AGREE II for methodological quality.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion</h3>\u0000 \u0000 <p>Key findings pertain to the normative significance of planetary health in guidelines and HTAs, scope and quality of included studies, inconsistencies in methods, and challenges in implementation. These findings will inform future Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) guidance on planetary health.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Registration</h3>\u0000 \u0000 <p>A protocol of this scoping review was registered in Open Science Framework (https://osf.io/3jmsa) and published in the journal Systematic Reviews (10.1186/s13643-024-02577-2).</p>\u0000 </section>\u0000 </div>","PeriodicalId":100266,"journal":{"name":"Clinical and Public Health Guidelines","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/gin2.70056","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145739895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protocol for the Development of The Australian Motor Neurone Disease (MND) Guideline 澳大利亚运动神经元疾病(MND)指南的制定方案
Pub Date : 2025-12-10 DOI: 10.1002/gin2.70055
Cindy Stern, Danielle Pollock, Timothy Barker, Grace McKenzie Holland, Sabira Hasanoff, Nipun Shrestha, Ines Semendric, Lemma Negesa Bulto, Sitasma Sharma, Anna Fragkoudi, Sebastian Cole Facchin-Young, Abigail Molly Day-Sharman, Lara Stollery, Jay Beasley-Hall, Camille Schubert, Lynne Giles, Tracy Merlin, Steve Vucic, Jo Whitehouse, Zachary Munn

Introduction

Motor neurone disease (MND) is a rare but devastating neurodegenerative condition that results in progressive muscle weakness, disability, and eventual respiratory failure. In Australia, the impact of MND is significant, and there is a pressing need for a high-quality, locally relevant guideline to support equitable, person-centred care.

Questions

This guideline aims to address key clinical and care-related questions that arise across the MND trajectory. It will identify the most pressing topics and uncertainties in MND management through interest holder consultation and structured prioritisation.

Methods

The guideline will be developed using the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach and will align with standards set by the National Health and Medical Research Council (NHMRC) and the Guidelines International Network (GIN). Governance will include a multi-tiered structure with lived experience representation. Implementation planning and evaluation will be integrated throughout, with a planned transition to a living guideline model supported by an ongoing evidence surveillance strategy.

运动神经元疾病(MND)是一种罕见但具有破坏性的神经退行性疾病,可导致进行性肌肉无力、残疾和最终的呼吸衰竭。在澳大利亚,MND的影响是巨大的,迫切需要一个高质量的、与当地相关的指导方针,以支持公平的、以人为本的护理。本指南旨在解决在MND发展过程中出现的关键临床和护理相关问题。它将通过利益相关者协商和结构化的优先顺序确定国防部管理中最紧迫的议题和不确定因素。该指南将采用GRADE(建议、评估、发展和评估分级)方法制定,并将与国家卫生和医学研究委员会(NHMRC)和国际指南网络(GIN)制定的标准保持一致。治理将包括一个具有生活经验代表的多层结构。实施规划和评价将贯穿始终,在持续的证据监测战略支持下有计划地过渡到生活指南模式。
{"title":"Protocol for the Development of The Australian Motor Neurone Disease (MND) Guideline","authors":"Cindy Stern,&nbsp;Danielle Pollock,&nbsp;Timothy Barker,&nbsp;Grace McKenzie Holland,&nbsp;Sabira Hasanoff,&nbsp;Nipun Shrestha,&nbsp;Ines Semendric,&nbsp;Lemma Negesa Bulto,&nbsp;Sitasma Sharma,&nbsp;Anna Fragkoudi,&nbsp;Sebastian Cole Facchin-Young,&nbsp;Abigail Molly Day-Sharman,&nbsp;Lara Stollery,&nbsp;Jay Beasley-Hall,&nbsp;Camille Schubert,&nbsp;Lynne Giles,&nbsp;Tracy Merlin,&nbsp;Steve Vucic,&nbsp;Jo Whitehouse,&nbsp;Zachary Munn","doi":"10.1002/gin2.70055","DOIUrl":"https://doi.org/10.1002/gin2.70055","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Motor neurone disease (MND) is a rare but devastating neurodegenerative condition that results in progressive muscle weakness, disability, and eventual respiratory failure. In Australia, the impact of MND is significant, and there is a pressing need for a high-quality, locally relevant guideline to support equitable, person-centred care.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Questions</h3>\u0000 \u0000 <p>This guideline aims to address key clinical and care-related questions that arise across the MND trajectory. It will identify the most pressing topics and uncertainties in MND management through interest holder consultation and structured prioritisation.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The guideline will be developed using the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach and will align with standards set by the National Health and Medical Research Council (NHMRC) and the Guidelines International Network (GIN). Governance will include a multi-tiered structure with lived experience representation. Implementation planning and evaluation will be integrated throughout, with a planned transition to a living guideline model supported by an ongoing evidence surveillance strategy.</p>\u0000 </section>\u0000 </div>","PeriodicalId":100266,"journal":{"name":"Clinical and Public Health Guidelines","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/gin2.70055","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145750905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Best Practice Guideline Development Methods: An Integrated Approach Based on the Registered Nurses' Association of Ontario's Methods 最佳实践指南开发方法:基于安大略省注册护士协会方法的综合方法
Pub Date : 2025-11-28 DOI: 10.1002/gin2.70052
Lyndsay Howitt, Amy Burt, Nafsin Nizum, Christine Buchanan, Michelle Rey, Doris Grinspun

Since 1999, the Registered Nurses' Association of Ontario (RNAO) has developed best practice guidelines (BPG) to promote consistency and quality of evidence-based care and improve patient, organization and health system outcomes. A distinguishing feature of RNAO's BPG development portfolio is its integration within RNAO's three-pillar BPG programme. This programme supports health service and academic organizations, Best Practice Spotlight Organizations® (BPSO®), to systematically implement, monitor and evaluate BPGs. Through formal partnerships with these organizations, the BPSO network extends the reach of the BPG programme and provides RNAO with direct feedback from end users, strengthening the relevance of future guideline editions. This article describes RNAO's integrated BPG development methods, outlining how evidence-based recommendations are made to support organizations implementing BPGs. Following extensive pre-development work to shape the purpose and scope of each guideline, an interprofessional expert panel that includes people with lived experience is appointed. Using the Grading of Recommendations, Assessment, Development and Evaluation methods, the expert panel prioritizes research questions and systematic reviews are conducted to determine strong or conditional recommendations. Good practice statements are also included and resources to support guideline implementation and evaluation are formulated including fact sheets, RNAO Clinical Pathways™ and evaluation measures. Draft guidelines undergo external review to ensure relevance and usability. To best serve the needs of organizations implementing BPGs, ongoing efforts are being made to keep RNAO's methods up-to-date and incorporate evaluation data from implementing organizations into the guideline development process.

自1999年以来,安大略省注册护士协会(RNAO)制定了最佳实践指南(BPG),以促进循证护理的一致性和质量,并改善患者、组织和卫生系统的结果。RNAO的BPG开发组合的一个显著特点是将其整合到RNAO的三支柱BPG计划中。该项目支持卫生服务和学术组织,即最佳实践重点组织®(BPSO®),系统地实施、监测和评估bpg。通过与这些组织的正式伙伴关系,BPSO网络扩展了BPG计划的范围,并向RNAO提供最终用户的直接反馈,加强了未来指南版本的相关性。本文描述了RNAO的集成BPG开发方法,概述了如何提出基于证据的建议来支持组织实施BPG。在进行了广泛的制定前工作以确定每项指南的目的和范围之后,任命了一个包括有实际经验人士在内的跨专业专家小组。采用建议分级、评估、发展和评估方法,专家小组对研究问题进行优先排序,并进行系统审查,以确定强烈或有条件的建议。还包括良好实践声明,并制定了支持指南实施和评估的资源,包括情况说明书、RNAO临床途径™和评估措施。准则草案经过外部审查,以确保相关性和可用性。为了最好地满足实施bpg的组织的需要,正在不断努力使RNAO的方法保持最新,并将实施组织的评估数据纳入指南开发过程。
{"title":"Best Practice Guideline Development Methods: An Integrated Approach Based on the Registered Nurses' Association of Ontario's Methods","authors":"Lyndsay Howitt,&nbsp;Amy Burt,&nbsp;Nafsin Nizum,&nbsp;Christine Buchanan,&nbsp;Michelle Rey,&nbsp;Doris Grinspun","doi":"10.1002/gin2.70052","DOIUrl":"https://doi.org/10.1002/gin2.70052","url":null,"abstract":"<p>Since 1999, the Registered Nurses' Association of Ontario (RNAO) has developed best practice guidelines (BPG) to promote consistency and quality of evidence-based care and improve patient, organization and health system outcomes. A distinguishing feature of RNAO's BPG development portfolio is its integration within RNAO's three-pillar BPG programme. This programme supports health service and academic organizations, Best Practice Spotlight Organizations® (BPSO®), to systematically implement, monitor and evaluate BPGs. Through formal partnerships with these organizations, the BPSO network extends the reach of the BPG programme and provides RNAO with direct feedback from end users, strengthening the relevance of future guideline editions. This article describes RNAO's integrated BPG development methods, outlining how evidence-based recommendations are made to support organizations implementing BPGs. Following extensive pre-development work to shape the purpose and scope of each guideline, an interprofessional expert panel that includes people with lived experience is appointed. Using the Grading of Recommendations, Assessment, Development and Evaluation methods, the expert panel prioritizes research questions and systematic reviews are conducted to determine strong or conditional recommendations. Good practice statements are also included and resources to support guideline implementation and evaluation are formulated including fact sheets, RNAO Clinical Pathways™ and evaluation measures. Draft guidelines undergo external review to ensure relevance and usability. To best serve the needs of organizations implementing BPGs, ongoing efforts are being made to keep RNAO's methods up-to-date and incorporate evaluation data from implementing organizations into the guideline development process.</p>","PeriodicalId":100266,"journal":{"name":"Clinical and Public Health Guidelines","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/gin2.70052","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145619328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Putting People at the Centre of Guidelines 以人为本
Pub Date : 2025-11-13 DOI: 10.1002/gin2.70054
Karen Graham, Naomi Fearns
<p>In our 30 years of producing guidelines, the Scottish Intercollegiate Guidelines Network (SIGN) has consistently adhered to the principles of Appraisal of Guidelines for Research and Evaluation (AGREE II) [<span>1</span>], prioritising Patient and Public Involvement (PPI) as set out in our SIGN 50 methodology handbook [<span>2</span>]. This commitment to PPI helps SIGN to produce high-quality clinical guidelines, that foster shared decision-making by recognising the outcomes that are important to people with lived experience, their values and their preferences [<span>3-8</span>]. Despite its value in guideline development, we recognise that more evaluation and research is needed to provide evidence of the impact of PPI on guideline quality, acceptability, implementation success and health outcomes [<span>9, 10</span>]. SIGN works in partnership with professionals, the third sector (non-profit organisations and charities), people with lived experience and the public, which enhances our guidelines credibility and helps us to tailor them to meet the real-world needs of all interest-holders [<span>5-8, 11, 12</span>]. In summary, PPI helps to make guideline recommendations better by incorporating patient preferences and values into them, and this helps guideline developers to achieve their aim of enhancing patient care and improving health outcomes [<span>3, 11-14</span>].</p><p>In this commentary we showcase the significance of PPI in the development of clinical guidelines by SIGN, using its dementia guideline [<span>15</span>], as a case example. We provide insights into SIGN's collaborative efforts, reinforcing the importance of diverse perspectives at each stage of the guideline development process.</p><p>The SIGN guideline on Assessment, diagnosis, care and support for people with dementia and their carers was published in 2023 [<span>15</span>]. It encourages all health and social care professionals to adopt person-centred care and treat people living with dementia and unpaid carers as individuals. The methodology we used for developing this guideline is outlined in SIGN 50 [<span>2</span>]. The quotes used to illustrate the commentary are drawn from feedback provided from carers and third sector organisation representatives gathered through surveys conducted during development of the guideline.</p><p>Representatives from third sector organisations and carers of people with dementia were members of our guideline development group and worked in partnership with professionals to produce the guideline. Carers played a crucial role in ensuring that issues that they saw as priorities, such as anticipatory grief, were thoroughly considered and addressed.</p><p>Third sector organisations invited people with dementia and their carers to participate in our guideline development processes to ensure diverse perspectives influenced decisions. We held multiple sessions with people with dementia, to ensure their perspectives were integrated into the wordi
在我们制定指南的30年里,苏格兰校际指南网络(SIGN)一直坚持研究和评估指南评估(AGREE II)[1]的原则,优先考虑患者和公众参与(PPI),正如我们的SIGN 50方法手册[2]中所述。这种对PPI的承诺有助于SIGN制定高质量的临床指南,通过认识到对有生活经验的人、他们的价值观和他们的偏好很重要的结果,促进共同决策[3-8]。尽管它在指南制定中有价值,但我们认识到需要更多的评估和研究来提供PPI对指南质量、可接受性、实施成功和健康结果的影响的证据[9,10]。SIGN与专业人士、第三部门(非营利组织和慈善机构)、有实际经验的人士和公众合作,这提高了我们指南的可信度,并帮助我们量身定制指南,以满足所有利益相关者的现实需求[5- 8,11,12]。总之,PPI通过将患者的偏好和价值观纳入指南建议中,有助于更好地制定指南建议,这有助于指南制定者实现其加强患者护理和改善健康结果的目标[3,11 -14]。在这篇评论中,我们以SIGN的痴呆指南[15]为例,展示了PPI在临床指南制定中的重要性。我们提供了对SIGN合作努力的见解,强调了在指南制定过程的每个阶段不同观点的重要性。关于痴呆症患者及其护理人员的评估、诊断、护理和支持的SIGN指南于2023年发布。它鼓励所有卫生和社会保健专业人员采取以人为本的护理,并将痴呆症患者和无薪护理人员作为个人对待。我们用于制定该指南的方法概述在SIGN 50[2]中。在指引制定期间进行的调查收集了护理员和第三界别机构代表的意见,并引用这些意见来说明上述评论。来自第三部门组织和痴呆症患者照顾者的代表是我们指南制定小组的成员,并与专业人士合作制定指南。护理人员在确保他们视为优先事项的问题(如预期悲伤)得到彻底考虑和解决方面发挥了关键作用。第三部门组织邀请痴呆症患者和他们的照顾者参与我们的指南制定过程,以确保不同的观点影响决策。我们与痴呆症患者举行了多次会议,以确保他们的观点融入指南的措辞和措辞,增强其实际相关性和真实性。这种合作方法旨在将指南建立在现实世界的经验和证据基础上,使其更适用于那些直接受痴呆症影响的人,并使其受益。支持有意义的参与需要大量的准备和计划,让合适的人参与进来。我们确保我们的流程是包容性的,并适应广泛的需求和偏好。作为指导小组会议的促进者,我们需要了解有生活经验的人的具体需求,确保他们有足够的时间和空间来表达自己。在让有生活经验的人参与痴呆症指南咨询会议时,我们实施了将认知障碍患者纳入其中的策略,以确保他们的声音得到倾听和重视。这种全面的PPI方法不仅丰富了决策过程,而且培养了一个更具包容性和同理心的环境。有效的沟通,并根据人们的支持需求做出合理的调整[2,12],可以让痴呆症患者分享他们的经验和观点。我们使用了一些技巧,比如在讨论中使用清晰、简单的语言,并允许额外的时间进行回应和重复。通过优先考虑这些战略,我们确保了痴呆症患者的声音得到倾听和重视。关于支持这项研究的平等考虑的更多细节,可以在平等影响评估报告中找到,该报告可在SIGN网站[14]上找到。我们直接询问痴呆症患者什么能帮助他们与我们沟通。这使他们能够表达自己的偏好和需求,从而形成一种更加以人为本的方法。我们量身定制了沟通策略,以更好地满足他们的个性化需求,提高他们的参与度和参与度。我们认识到允许护理人员陪同痴呆症患者参加会议的重要性。 我们发现,护理人员帮助理解痴呆症患者的需求和偏好,并确保他们的担忧得到充分解决。平衡指南制定小组内部的权力动态对于支持所有利益相关者能够做出贡献至关重要。如果不解决权力不平衡问题,指导方针的制定过程很可能有利于更多直言不讳的参与者。我们试图公平地接纳每一个人,鼓励所有的声音都被听到。虽然由于他们的观点和知识基础不同,有经验的人与专业人士之间存在一些分歧,但这种思想的多样性最终丰富了团队的集体思维。在指南制定过程的研究问题设定阶段,认识权力动力学重要性的一个例子是显而易见的。在指引会议上,主席提醒小组成员有一名护理员的价值,并预留时间让护理员和第三界别代表就问题交换意见。因此,根据他们的输入,增加了一个额外的研究问题。小组成员的反馈表明,如果照顾者和第三部门的代表没有被保护时间来表达他们的意见,这个领域就会被忽视。在范围界定、研究问题设置和咨询阶段(包括对指南草案的反馈)纳入具有实际经验的人的见解,可增强指南的相关性和有效性[8,17]。作为指南制定小组成员的参与确保在制定过程中考虑到人们的观点,并培养对指南的所有权和信任感。通过咨询从有生活经验的人那里收集许多意见,可以考虑更广泛的经验和选择,有助于使指南更全面,反映社区的需求[5,7,10,12,16 -18]。一个值得注意的例子是,由于护理人员对指导小组的投入,在痴呆的各个阶段纳入了一个关于悲伤管理的研究问题。为了更好地反映痴呆症患者的观点和需求,我们修改了诊断后支持指南中的信息图表。这些变化确保了指导方针不仅在理论上是合理的,而且在实践中是适用和支持的。咨询后做出的一项重要改变是基于一位痴呆症患者的评论,该评论强调了对痴呆症患者进行定期审查和预期护理计划(acp)的重要性。虽然没有法律要求,但该指南进行了更新,以反映ACP定期审查的良好做法,表明患者和公众参与的积极影响。SIGN对患者和公众参与的承诺有助于制定高质量的以人为本的指南。通过让专业人士、第三部门机构和有实际经验的人士参与进来,我们建立了一个更具包容性和响应性的指南制定过程。这种方法在我们的痴呆症指南中尤为明显,它确保了指南既以证据为基础,又以现实世界的经验为基础。将患者和公众参与纳入痴呆症的SIGN指南提出了挑战,如平衡不同的观点,克服沟通障碍和管理情感讨论。通过包容性参与、创造支持性环境和量身定制的沟通策略,解决了这些问题。痴呆指南中PPI的好处包括增加利益相关者的参与,增强对指南的信任,以及为所有利益相关者提供实用和相关的建议。凯伦格雷厄姆:写作-原始草案,写作-审查和编辑。Naomi Fearns:写作-原稿,写作-审查和编辑。作者声明无利益冲突。数据共享不适用于本文,因为本研究没有创建或分析新的数据。
{"title":"Putting People at the Centre of Guidelines","authors":"Karen Graham,&nbsp;Naomi Fearns","doi":"10.1002/gin2.70054","DOIUrl":"https://doi.org/10.1002/gin2.70054","url":null,"abstract":"&lt;p&gt;In our 30 years of producing guidelines, the Scottish Intercollegiate Guidelines Network (SIGN) has consistently adhered to the principles of Appraisal of Guidelines for Research and Evaluation (AGREE II) [&lt;span&gt;1&lt;/span&gt;], prioritising Patient and Public Involvement (PPI) as set out in our SIGN 50 methodology handbook [&lt;span&gt;2&lt;/span&gt;]. This commitment to PPI helps SIGN to produce high-quality clinical guidelines, that foster shared decision-making by recognising the outcomes that are important to people with lived experience, their values and their preferences [&lt;span&gt;3-8&lt;/span&gt;]. Despite its value in guideline development, we recognise that more evaluation and research is needed to provide evidence of the impact of PPI on guideline quality, acceptability, implementation success and health outcomes [&lt;span&gt;9, 10&lt;/span&gt;]. SIGN works in partnership with professionals, the third sector (non-profit organisations and charities), people with lived experience and the public, which enhances our guidelines credibility and helps us to tailor them to meet the real-world needs of all interest-holders [&lt;span&gt;5-8, 11, 12&lt;/span&gt;]. In summary, PPI helps to make guideline recommendations better by incorporating patient preferences and values into them, and this helps guideline developers to achieve their aim of enhancing patient care and improving health outcomes [&lt;span&gt;3, 11-14&lt;/span&gt;].&lt;/p&gt;&lt;p&gt;In this commentary we showcase the significance of PPI in the development of clinical guidelines by SIGN, using its dementia guideline [&lt;span&gt;15&lt;/span&gt;], as a case example. We provide insights into SIGN's collaborative efforts, reinforcing the importance of diverse perspectives at each stage of the guideline development process.&lt;/p&gt;&lt;p&gt;The SIGN guideline on Assessment, diagnosis, care and support for people with dementia and their carers was published in 2023 [&lt;span&gt;15&lt;/span&gt;]. It encourages all health and social care professionals to adopt person-centred care and treat people living with dementia and unpaid carers as individuals. The methodology we used for developing this guideline is outlined in SIGN 50 [&lt;span&gt;2&lt;/span&gt;]. The quotes used to illustrate the commentary are drawn from feedback provided from carers and third sector organisation representatives gathered through surveys conducted during development of the guideline.&lt;/p&gt;&lt;p&gt;Representatives from third sector organisations and carers of people with dementia were members of our guideline development group and worked in partnership with professionals to produce the guideline. Carers played a crucial role in ensuring that issues that they saw as priorities, such as anticipatory grief, were thoroughly considered and addressed.&lt;/p&gt;&lt;p&gt;Third sector organisations invited people with dementia and their carers to participate in our guideline development processes to ensure diverse perspectives influenced decisions. We held multiple sessions with people with dementia, to ensure their perspectives were integrated into the wordi","PeriodicalId":100266,"journal":{"name":"Clinical and Public Health Guidelines","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/gin2.70054","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145521883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strengthening the Clinical Practice Guideline Ecosystem 加强临床实践指南生态系统
Pub Date : 2025-11-12 DOI: 10.1002/gin2.70051
Nan Yang, Dong Roman Xu, Janne Estill, Yaolong Chen

The concept of clinical practice guideline has existed for over 30 years, but guidelines still face numerous limitations, including low methodological quality, inadequate reporting transparency, slow implementation, and infrequent updates [1, 2]. There are several barriers in the dynamics between the different steps of the entire process, ranging from guideline development to implementation for which improvements are warranted [3, 4]. The establishment of a cohesive and well-coordinated guideline ecosystem could help to eliminate many barriers across the entire process from development to implementation and address the existing challenges.

The guideline ecosystem encompasses more than the above steps, but we believe these seven are the most fundamental ones and deserve particular attention. Each of the steps will require a thorough evaluation of the current situation, as well as the development of a standardised framework. A standardised framework will outline the relationships between the different steps of the guideline ecosystem, which in turn will help to promote the development, implementation, and updating of high-quality guidelines in a coordinated and transparent manner.

Nan Yang: conceptualization, writing — original draft, visualization. Dong Roman Xu: writing — review and editing, supervision Janne Estill: methodology, writing — review and editing. Yaolong Chen: conceptualization, writing — review and editing, supervision, funding acquisition. All authors have read and approved the final manuscript.

The authors declare no conflict of interest. Yaolong Chen is the cofounder and cochair of RIGHT (Reporting Items for Practice Guidelines in Healthcare).

All relevant data are within the manuscript.

临床实践指南的概念已经存在了30多年,但指南仍然面临许多限制,包括方法质量低,报告透明度不足,实施缓慢,更新不频繁[1,2]。在整个过程的不同步骤之间的动态中存在一些障碍,从指南制定到需要改进的实施[3,4]。建立一个有凝聚力和良好协调的指南生态系统可以帮助消除从开发到实施的整个过程中的许多障碍,并解决现有的挑战。指南生态系统包含的步骤比上述的多,但我们认为这七个是最基本的,值得特别关注。每一个步骤都需要对目前的情况进行彻底的评估,并制定一个标准化的框架。标准化框架将概述指南生态系统中不同步骤之间的关系,这反过来将有助于以协调和透明的方式促进高质量指南的制定、实施和更新。南阳:概念化,写稿,形象化。徐东罗曼:写作-审查和编辑,监督。珍妮·斯蒂尔:方法论,写作-审查和编辑。陈耀龙:构思、撰写、审编、监督、经费获取。所有作者都阅读并批准了最终稿件。作者声明无利益冲突。陈耀龙是RIGHT(医疗保健实践指南报告项目)的联合创始人和联合主席。所有相关数据都在稿件中。
{"title":"Strengthening the Clinical Practice Guideline Ecosystem","authors":"Nan Yang,&nbsp;Dong Roman Xu,&nbsp;Janne Estill,&nbsp;Yaolong Chen","doi":"10.1002/gin2.70051","DOIUrl":"https://doi.org/10.1002/gin2.70051","url":null,"abstract":"<p>The concept of clinical practice guideline has existed for over 30 years, but guidelines still face numerous limitations, including low methodological quality, inadequate reporting transparency, slow implementation, and infrequent updates [<span>1, 2</span>]. There are several barriers in the dynamics between the different steps of the entire process, ranging from guideline development to implementation for which improvements are warranted [<span>3, 4</span>]. The establishment of a cohesive and well-coordinated guideline ecosystem could help to eliminate many barriers across the entire process from development to implementation and address the existing challenges.</p><p>The guideline ecosystem encompasses more than the above steps, but we believe these seven are the most fundamental ones and deserve particular attention. Each of the steps will require a thorough evaluation of the current situation, as well as the development of a standardised framework. A standardised framework will outline the relationships between the different steps of the guideline ecosystem, which in turn will help to promote the development, implementation, and updating of high-quality guidelines in a coordinated and transparent manner.</p><p><b>Nan Yang:</b> conceptualization, writing — original draft, visualization. <b>Dong Roman Xu:</b> writing — review and editing, supervision <b>Janne Estill:</b> methodology, writing — review and editing. <b>Yaolong Chen:</b> conceptualization, writing — review and editing, supervision, funding acquisition. All authors have read and approved the final manuscript.</p><p>The authors declare no conflict of interest. Yaolong Chen is the cofounder and cochair of RIGHT (Reporting Items for Practice Guidelines in Healthcare).</p><p>All relevant data are within the manuscript.</p>","PeriodicalId":100266,"journal":{"name":"Clinical and Public Health Guidelines","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/gin2.70051","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145521839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding the Determinants That Influence the Development and Implementation of Evidence-Based Practice Guidelines During Health Emergencies: An Exploratory Sequential Mixed-Methods Study Protocol 了解影响突发卫生事件中循证实践指南制定和实施的决定因素:一项探索性顺序混合方法研究方案
Pub Date : 2025-11-04 DOI: 10.1002/gin2.70047
Gonzalo Bravo-Soto, Shelly-Anne Li, Gordon Guyatt, Nancy Santesso, Susan M. Jack, Thomas Agoritsas, Francois Lamontagne, John Lavis, Reem A. Mustafa, Bram Rochwerg, Wojtek Wiercioch, Linan Zeng, Ludovic Reveiz, Romina Brignardello-Petersen

Introduction

The COVID-19 pandemic highlighted the crucial role of evidence-based practice guidelines (EBPGs) in healthcare systems. Reliable and timely guidelines are essential in health emergencies. This study aims to identify and comprehensively understand the determinants that influence the development and implementation of EBPGs during health emergencies from the perspective of guideline developers and implementers. In this article, we describe the study protocol.

Methodology

We will conduct an exploratory sequential mixed-methods study composed of four phases: (I) a qualitative descriptive study to document the experiences of guideline developers and implementers and use this data to generate a list of determinants that influence the development and implementation of EBPG; (II) exploratory integration for survey development and validation using the data of phase I; (III) cross-sectional study to administer the survey to a large sample and estimate the frequency and perceived impact of those determinants; (IV) interpretation of the results: a combination of qualitative and quantitative findings through the narrative description and joint displays to generate a comprehensive understanding of those determinants. We will explore if results vary across subgroups of interest (participants' roles, gender, and type of organization). We will include people worldwide from five groups participating in an EBPG development and implementation process during the pandemic.

Discussion

This study will provide insights into the determinants that influence the development and implementation of EBPGs during health emergencies. Its potential impact includes improving future health emergency preparedness, addressing equity gaps, and enhancing guideline development and implementation.

2019冠状病毒病大流行凸显了循证实践指南(ebpg)在医疗保健系统中的关键作用。在突发卫生事件中,可靠和及时的指导方针至关重要。本研究旨在从指南制定者和实施者的角度,识别并全面了解影响突发卫生事件中ebpg制定和实施的决定因素。在本文中,我们描述了研究方案。我们将进行一项探索性顺序混合方法研究,包括四个阶段:(I)定性描述性研究,记录指南制定者和实施者的经验,并使用这些数据生成影响EBPG发展和实施的决定因素清单;(二)探索性整合,利用第一阶段数据进行调查开发和验证;(III)横断面研究,对大样本进行调查,并估计这些决定因素的频率和感知影响;(IV)结果解释:通过叙述性描述和联合展示,将定性和定量发现相结合,以产生对这些决定因素的全面理解。我们将探讨结果是否在兴趣子组(参与者的角色、性别和组织类型)中有所不同。我们将包括来自世界各地在大流行期间参与EBPG制定和实施过程的五个小组的人员。本研究将深入了解突发卫生事件期间影响ebpg制定和实施的决定因素。其潜在影响包括改善未来的卫生应急准备,解决公平差距,以及加强指南的制定和实施。
{"title":"Understanding the Determinants That Influence the Development and Implementation of Evidence-Based Practice Guidelines During Health Emergencies: An Exploratory Sequential Mixed-Methods Study Protocol","authors":"Gonzalo Bravo-Soto,&nbsp;Shelly-Anne Li,&nbsp;Gordon Guyatt,&nbsp;Nancy Santesso,&nbsp;Susan M. Jack,&nbsp;Thomas Agoritsas,&nbsp;Francois Lamontagne,&nbsp;John Lavis,&nbsp;Reem A. Mustafa,&nbsp;Bram Rochwerg,&nbsp;Wojtek Wiercioch,&nbsp;Linan Zeng,&nbsp;Ludovic Reveiz,&nbsp;Romina Brignardello-Petersen","doi":"10.1002/gin2.70047","DOIUrl":"https://doi.org/10.1002/gin2.70047","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>The COVID-19 pandemic highlighted the crucial role of evidence-based practice guidelines (EBPGs) in healthcare systems. Reliable and timely guidelines are essential in health emergencies. This study aims to identify and comprehensively understand the determinants that influence the development and implementation of EBPGs during health emergencies from the perspective of guideline developers and implementers. In this article, we describe the study protocol.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methodology</h3>\u0000 \u0000 <p>We will conduct an exploratory sequential mixed-methods study composed of four phases: (I) a qualitative descriptive study to document the experiences of guideline developers and implementers and use this data to generate a list of determinants that influence the development and implementation of EBPG; (II) exploratory integration for survey development and validation using the data of phase I; (III) cross-sectional study to administer the survey to a large sample and estimate the frequency and perceived impact of those determinants; (IV) interpretation of the results: a combination of qualitative and quantitative findings through the narrative description and joint displays to generate a comprehensive understanding of those determinants. We will explore if results vary across subgroups of interest (participants' roles, gender, and type of organization). We will include people worldwide from five groups participating in an EBPG development and implementation process during the pandemic.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion</h3>\u0000 \u0000 <p>This study will provide insights into the determinants that influence the development and implementation of EBPGs during health emergencies. Its potential impact includes improving future health emergency preparedness, addressing equity gaps, and enhancing guideline development and implementation.</p>\u0000 </section>\u0000 </div>","PeriodicalId":100266,"journal":{"name":"Clinical and Public Health Guidelines","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/gin2.70047","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145469532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing and Assessing Clinical Practice Guidelines and Consensus Statements for Healthy Athletes: A Scoping Review Protocol 比较和评估健康运动员的临床实践指南和共识声明:范围审查协议
Pub Date : 2025-10-29 DOI: 10.1002/gin2.70050
Samyan Shahid, Andres Estupiñán-Bohórquez

Introduction

Healthy athletes have unique physiological, psychological, and interpersonal needs that necessitate individualized prevention and management strategies. As such, this comprehensive protocol has been created to illustrate the scope, quality and coverage of these clinical practice guidelines (CPGs) and consensus statements among this specific population.

Methods and Analysis

Searches will be conducted in PubMed, Scopus, SPORTDiscus, Web of Science, EMBASE, Google Scholar and any grey literature within official international organizations. Eligible publications will include CPGs and consensus statements that are aimed towards healthy athletes, published in English or Spanish since 2000. The AGREE II instrument will be applied to assess the quality of the guidelines by two independent reviewers. Disagreements will be resolved by a third reviewer. We will use descriptive statistics to summarize the main characteristics of the guidelines.

Discussion

This scoping review seeks towards providing an in-depth analysis on the mapping, explaining, and evaluating of the available CPGs and consensus statements of the population of healthy athletes. Moreover, it will identify thematic trends, methodological strengths, and potential evidence gaps that currently exist. Fundamentally, the results will provide valuable information towards development of guidelines, standardization efforts, and evidence-based practice in the future within the field of sports medicine.

健康的运动员有独特的生理、心理和人际需求,需要个性化的预防和管理策略。因此,本综合协议的创建是为了说明这些临床实践指南(cpg)的范围、质量和覆盖范围,以及在这一特定人群中的共识声明。方法和分析检索将在PubMed, Scopus, SPORTDiscus, Web of Science, EMBASE,谷歌Scholar和任何官方国际组织的灰色文献中进行。符合条件的出版物将包括2000年以来以英语或西班牙语出版的针对健康运动员的cpg和共识声明。两名独立审稿人将采用AGREE II工具来评估指南的质量。分歧将由第三位审稿人解决。我们将使用描述性统计来总结指南的主要特征。本综述旨在对现有cpg的绘制、解释和评估以及健康运动员群体的共识陈述进行深入分析。此外,它将确定主题趋势、方法优势和目前存在的潜在证据差距。从根本上说,这些结果将为未来运动医学领域的指导方针、标准化工作和循证实践的发展提供有价值的信息。
{"title":"Comparing and Assessing Clinical Practice Guidelines and Consensus Statements for Healthy Athletes: A Scoping Review Protocol","authors":"Samyan Shahid,&nbsp;Andres Estupiñán-Bohórquez","doi":"10.1002/gin2.70050","DOIUrl":"https://doi.org/10.1002/gin2.70050","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Healthy athletes have unique physiological, psychological, and interpersonal needs that necessitate individualized prevention and management strategies. As such, this comprehensive protocol has been created to illustrate the scope, quality and coverage of these clinical practice guidelines (CPGs) and consensus statements among this specific population.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods and Analysis</h3>\u0000 \u0000 <p>Searches will be conducted in PubMed, Scopus, SPORTDiscus, Web of Science, EMBASE, Google Scholar and any grey literature within official international organizations. Eligible publications will include CPGs and consensus statements that are aimed towards healthy athletes, published in English or Spanish since 2000. The AGREE II instrument will be applied to assess the quality of the guidelines by two independent reviewers. Disagreements will be resolved by a third reviewer. We will use descriptive statistics to summarize the main characteristics of the guidelines.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion</h3>\u0000 \u0000 <p>This scoping review seeks towards providing an in-depth analysis on the mapping, explaining, and evaluating of the available CPGs and consensus statements of the population of healthy athletes. Moreover, it will identify thematic trends, methodological strengths, and potential evidence gaps that currently exist. Fundamentally, the results will provide valuable information towards development of guidelines, standardization efforts, and evidence-based practice in the future within the field of sports medicine.</p>\u0000 </section>\u0000 </div>","PeriodicalId":100266,"journal":{"name":"Clinical and Public Health Guidelines","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/gin2.70050","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145375236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recommendation Map for Type 2 Diabetes: A Protocol for a Living Systematic Review of Clinical Practice Guidelines 2型糖尿病推荐图:临床实践指南的生活系统评价方案
Pub Date : 2025-10-13 DOI: 10.1002/gin2.70049
Qiyi Zhang, Shichun Wang, Kang An, Arnav Agarwal, Britta Tendal Jeppesen, Per Olav Vandvik, Thomas Agoritsas, Heath White, Jun Tang, Wanru Wang, Chuanfeng Tao, Yaolong Chen, Sheyu Li, Yinghui Jin

Introduction

The global burden of type 2 diabetes, emergence of numerous new therapeutics and rapidly evolving evidence calls for trustworthy and current clinical practice guidelines (CPGs). This living systematic review of national and international CPGs aims to iteratively summarize recommendations for the management of type 2 diabetes.

Method and Analysis

We will search electronic databases, professional academic association websites and guideline repositories from 2010 to April 1 2024 for national, international, or professional society CPGs addressing the management of type 2 diabetes. Our initial search will be followed by quarterly literature searches. Paired reviewers will independently assess the quality of identified CPGs using AGREE-II. Recommendations and their associated methodological quality will be summarized and made available via a user-friendly interactive online platform.

Discussion

This living systematic review of CPGs will enable clinicians, patients and system-level decision-makers to inform their decision-making based on internationally available CPGs. It will also allow methodologists to identify gaps in evidence and recommendations to inform future directions in research and CPGs development.

PROSPERO Registration Number

CRD42023466448 (https://www.crd.york.ac.uk/PROSPERO/).

2型糖尿病的全球负担、众多新治疗方法的出现以及快速发展的证据要求制定可靠的现行临床实践指南(cpg)。这篇对国家和国际CPGs的系统回顾旨在反复总结2型糖尿病管理的建议。方法与分析我们将检索2010年至2024年4月1日期间的电子数据库、专业学术协会网站和指南库,以获取涉及2型糖尿病管理的国家、国际或专业协会cpg。我们最初的搜索之后将是每季度的文献搜索。配对审稿人将使用AGREE-II独立评估鉴定的cpg的质量。将总结建议及其相关的方法质量,并通过用户友好的交互式在线平台提供。这种对cpg的实时系统回顾将使临床医生、患者和系统级决策者能够根据国际上可用的cpg进行决策。它还将使方法学家能够确定证据和建议方面的差距,从而为研究和CPGs开发的未来方向提供信息。普洛斯彼罗注册号CRD42023466448 (https://www.crd.york.ac.uk/PROSPERO/)。
{"title":"Recommendation Map for Type 2 Diabetes: A Protocol for a Living Systematic Review of Clinical Practice Guidelines","authors":"Qiyi Zhang,&nbsp;Shichun Wang,&nbsp;Kang An,&nbsp;Arnav Agarwal,&nbsp;Britta Tendal Jeppesen,&nbsp;Per Olav Vandvik,&nbsp;Thomas Agoritsas,&nbsp;Heath White,&nbsp;Jun Tang,&nbsp;Wanru Wang,&nbsp;Chuanfeng Tao,&nbsp;Yaolong Chen,&nbsp;Sheyu Li,&nbsp;Yinghui Jin","doi":"10.1002/gin2.70049","DOIUrl":"https://doi.org/10.1002/gin2.70049","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>The global burden of type 2 diabetes, emergence of numerous new therapeutics and rapidly evolving evidence calls for trustworthy and current clinical practice guidelines (CPGs). This living systematic review of national and international CPGs aims to iteratively summarize recommendations for the management of type 2 diabetes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method and Analysis</h3>\u0000 \u0000 <p>We will search electronic databases, professional academic association websites and guideline repositories from 2010 to April 1 2024 for national, international, or professional society CPGs addressing the management of type 2 diabetes. Our initial search will be followed by quarterly literature searches. Paired reviewers will independently assess the quality of identified CPGs using AGREE-II. Recommendations and their associated methodological quality will be summarized and made available via a user-friendly interactive online platform.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion</h3>\u0000 \u0000 <p>This living systematic review of CPGs will enable clinicians, patients and system-level decision-makers to inform their decision-making based on internationally available CPGs. It will also allow methodologists to identify gaps in evidence and recommendations to inform future directions in research and CPGs development.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> PROSPERO Registration Number</h3>\u0000 \u0000 <p>CRD42023466448 (https://www.crd.york.ac.uk/PROSPERO/).</p>\u0000 </section>\u0000 </div>","PeriodicalId":100266,"journal":{"name":"Clinical and Public Health Guidelines","volume":"2 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/gin2.70049","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145316885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating Environmental Sustainability Into Evidence-Based Clinical Guidelines: Methodological Guidance Report 将环境可持续性纳入循证临床指南:方法学指导报告
Pub Date : 2025-09-24 DOI: 10.1002/gin2.70046
Kim E. van Nieuwenhuizen, Jeroen B. Guinée, Miranda W. Langendam, Pauline de Heer, Stefanie N. Hofstede, Frank Willem Jansen, Charlotte T. J. Michels, Dutch Expert Panel

Introduction

The global healthcare sector significantly contributes to climate change and other environmental impacts. Despite this, environmental sustainability considerations are often missing from evidence-based clinical guidelines. To address this gap, we developed a methodological guidance report focused on integrating environmental sustainability into clinical guidelines.

Methods

An interdisciplinary expert panel systematically developed this methodological guidance report. Data collection involved expert panel meetings and consultations with stakeholders, based on the development of a sustainability guideline focused on reducing the environmental impact of the operating room (OR). The process included an initial inventory and prioritisation phase, guideline development following the GRADE approach, and finalisation and publication.

Results

The generated insights offer a standardised and readily applicable guidance report for integrating environmental sustainability into clinical guidelines across medical disciplines. This allows guideline developers to implement sustainability considerations in clinical guidelines. Environmental sustainability should be addressed at the start of guideline development, involving interdisciplinary experts. Approaches include integrating environmental outcomes into the PICO framework or adding a search question focused on the environmental impact of interventions. Furthermore, environmental sustainability should be integrated in the Evidence-to-Decision framework. If LCAs are included, both the critical appraisal for study quality of LCAs and the GRADE approach for quality of the evidence are recommended.

Interpretation

This methodological guidance report facilitates a stepwise approach of integrating environmental sustainability into clinical practice through evidence-based guideline development. While further evaluation and implementation in clinical practice is needed, the framework supports more sustainable clinical decision-making and contributes to promoting planetary health.

全球医疗保健部门对气候变化和其他环境影响做出了重大贡献。尽管如此,基于证据的临床指南往往缺少对环境可持续性的考虑。为了解决这一差距,我们开发了一份方法指导报告,重点是将环境可持续性纳入临床指南。方法由跨学科专家小组系统编制方法学指导报告。数据收集涉及专家小组会议和与利益相关者的磋商,以制定可持续发展指南为基础,重点是减少手术室(OR)的环境影响。该过程包括初始清单和优先排序阶段,按照GRADE方法制定指南,以及最终定稿和发布。结果生成的见解为将环境可持续性纳入医学学科的临床指南提供了标准化和易于应用的指导报告。这允许指南开发者在临床指南中实施可持续性考虑。环境可持续性应在准则制定之初就得到处理,并由跨学科专家参与。方法包括将环境结果纳入PICO框架或增加一个关注干预措施对环境影响的搜索问题。此外,环境可持续性应纳入从证据到决策的框架。如果包括lca,则建议对lca的研究质量进行批判性评价,并对证据质量采用GRADE方法。本方法学指导报告通过循证指南的制定,促进了将环境可持续性纳入临床实践的逐步方法。虽然需要在临床实践中进一步评价和执行,但该框架支持更可持续的临床决策,并有助于促进地球健康。
{"title":"Integrating Environmental Sustainability Into Evidence-Based Clinical Guidelines: Methodological Guidance Report","authors":"Kim E. van Nieuwenhuizen,&nbsp;Jeroen B. Guinée,&nbsp;Miranda W. Langendam,&nbsp;Pauline de Heer,&nbsp;Stefanie N. Hofstede,&nbsp;Frank Willem Jansen,&nbsp;Charlotte T. J. Michels,&nbsp;Dutch Expert Panel","doi":"10.1002/gin2.70046","DOIUrl":"https://doi.org/10.1002/gin2.70046","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>The global healthcare sector significantly contributes to climate change and other environmental impacts. Despite this, environmental sustainability considerations are often missing from evidence-based clinical guidelines. To address this gap, we developed a methodological guidance report focused on integrating environmental sustainability into clinical guidelines.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>An interdisciplinary expert panel systematically developed this methodological guidance report. Data collection involved expert panel meetings and consultations with stakeholders, based on the development of a sustainability guideline focused on reducing the environmental impact of the operating room (OR). The process included an initial inventory and prioritisation phase, guideline development following the GRADE approach, and finalisation and publication.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The generated insights offer a standardised and readily applicable guidance report for integrating environmental sustainability into clinical guidelines across medical disciplines. This allows guideline developers to implement sustainability considerations in clinical guidelines. Environmental sustainability should be addressed at the start of guideline development, involving interdisciplinary experts. Approaches include integrating environmental outcomes into the PICO framework or adding a search question focused on the environmental impact of interventions. Furthermore, environmental sustainability should be integrated in the Evidence-to-Decision framework. If LCAs are included, both the critical appraisal for study quality of LCAs and the GRADE approach for quality of the evidence are recommended.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Interpretation</h3>\u0000 \u0000 <p>This methodological guidance report facilitates a stepwise approach of integrating environmental sustainability into clinical practice through evidence-based guideline development. While further evaluation and implementation in clinical practice is needed, the framework supports more sustainable clinical decision-making and contributes to promoting planetary health.</p>\u0000 </section>\u0000 </div>","PeriodicalId":100266,"journal":{"name":"Clinical and Public Health Guidelines","volume":"2 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/gin2.70046","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145146540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Algorithm for Incorporating Economic Evidence Into Clinical Practice Guidelines: Application to the Spanish Guideline for the Management of Chronic Primary Pain 将经济证据纳入临床实践指南的算法:应用于西班牙慢性原发性疼痛管理指南
Pub Date : 2025-09-24 DOI: 10.1002/gin2.70045
Celia Muñoz, Patricia Gavín-Benavent, Silvia Moler-Zapata, Lucía Prieto Remón, María Bono Vega, Soledad Isern de Val, on behalf of GuíaSalud's Working Group on Incorporating Economic Evidence into CPGs

The importance of incorporating economic evidence (EE) such as resource use, cost or cost-effectiveness evidence into Clinical Practice Guidelines (CPG) is being increasingly recognised by decision makers, including healthcare providers and policy makers. Yet, this is a complex and resource-intensive process. EE can influence recommendations formulated about interventions in CPGs, especially when the desirable and undesirable effects are balanced. A group of methodologists, including health economists, in GuíaSalud (the organisation of the Spanish National Health System (NHS) that coordinates the national CPG Programme), has made important advances in the development of methodological guidance for how to develop evidence-based recommendations. In this article, we present an algorithm for informing decisions about incorporating EE in CPGs. The algorithm has three stages: (1) prioritise clinical questions in the CPG according to the influence that EE is expected to have on recommendations; (2) obtain EE for clinical questions that have been prioritised via a systematic review and/or a de novo economic evaluation; and (3) use EE to inform recommendations in CPG. We show how the algorithm was applied in the development of GuíaSalud's CPG for the management of chronic primary pain. In doing so, we provide specific guidance on how the algorithm could be applied using concrete examples. We show how this algorithm helps to make the process of incorporating EE into CPGs agile, dynamic and reproducible.

将经济证据(EE),如资源利用、成本或成本效益证据纳入临床实践指南(CPG)的重要性正日益被决策者(包括医疗保健提供者和政策制定者)认识到。然而,这是一个复杂和资源密集的过程。情感表达可以影响关于cpg干预措施的建议,特别是当期望和不期望的效果达到平衡时。在GuíaSalud(西班牙国家卫生系统协调国家CPG方案的组织),包括卫生经济学家在内的一组方法学家在制定如何制定循证建议的方法指导方面取得了重要进展。在本文中,我们提出了一种算法,用于通知将EE纳入cpg的决策。该算法分为三个阶段:(1)根据预期情感表达对推荐的影响对CPG中的临床问题进行优先排序;(2)获得通过系统评价和/或重新进行经济评估优先考虑的临床问题的情感表达;(3)在CPG中使用情感表达来提供建议。我们展示了该算法如何应用于GuíaSalud的CPG开发中,用于慢性原发性疼痛的管理。在此过程中,我们提供了如何使用具体示例应用该算法的具体指导。我们将展示该算法如何帮助将EE纳入cpg的过程变得敏捷、动态和可重复。
{"title":"An Algorithm for Incorporating Economic Evidence Into Clinical Practice Guidelines: Application to the Spanish Guideline for the Management of Chronic Primary Pain","authors":"Celia Muñoz,&nbsp;Patricia Gavín-Benavent,&nbsp;Silvia Moler-Zapata,&nbsp;Lucía Prieto Remón,&nbsp;María Bono Vega,&nbsp;Soledad Isern de Val,&nbsp;on behalf of GuíaSalud's Working Group on Incorporating Economic Evidence into CPGs","doi":"10.1002/gin2.70045","DOIUrl":"https://doi.org/10.1002/gin2.70045","url":null,"abstract":"<p>The importance of incorporating economic evidence (EE) such as resource use, cost or cost-effectiveness evidence into Clinical Practice Guidelines (CPG) is being increasingly recognised by decision makers, including healthcare providers and policy makers. Yet, this is a complex and resource-intensive process. EE can influence recommendations formulated about interventions in CPGs, especially when the desirable and undesirable effects are balanced. A group of methodologists, including health economists, in GuíaSalud (the organisation of the Spanish National Health System (NHS) that coordinates the national CPG Programme), has made important advances in the development of methodological guidance for how to develop evidence-based recommendations. In this article, we present an algorithm for informing decisions about incorporating EE in CPGs. The algorithm has three stages: (1) prioritise clinical questions in the CPG according to the influence that EE is expected to have on recommendations; (2) obtain EE for clinical questions that have been prioritised via a systematic review and/or a <i>de novo</i> economic evaluation; and (3) use EE to inform recommendations in CPG. We show how the algorithm was applied in the development of GuíaSalud's CPG for the management of chronic primary pain. In doing so, we provide specific guidance on how the algorithm could be applied using concrete examples. We show how this algorithm helps to make the process of incorporating EE into CPGs agile, dynamic and reproducible.</p>","PeriodicalId":100266,"journal":{"name":"Clinical and Public Health Guidelines","volume":"2 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/gin2.70045","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145146539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical and Public Health Guidelines
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1